{"transactions":[{"id":4628562,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-10-02T23:54:44.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":1528513,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000907654-26-000104","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000090765426000104/form4.xml","form_type":"4"}},{"id":4628561,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-02T23:54:44.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":200,"price":84.78,"value":16956.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.75 to $84.81, inclusive."}],"balance_after":923128,"source":{"system":"sec-edgar","filing":"0000907654-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000090765426000104/form4.xml","form_type":"4"}},{"id":4628560,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-02T23:54:44.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":8554,"price":84.0256,"value":718754.9824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.69, inclusive."}],"balance_after":923328,"source":{"system":"sec-edgar","filing":"0000907654-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000090765426000104/form4.xml","form_type":"4"}},{"id":4628559,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-02T23:54:44.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":16246,"price":83.3979,"value":1354882.2834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.75 to $83.73, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":931882,"source":{"system":"sec-edgar","filing":"0000907654-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000090765426000104/form4.xml","form_type":"4"}},{"id":4628558,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-02T23:54:44.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":7.8,"value":195000.0,"ownership":{"direct":true},"balance_after":948128,"source":{"system":"sec-edgar","filing":"0000907654-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000090765426000104/form4.xml","form_type":"4"}},{"id":4618689,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:15:17.000Z","date":"2026-09-15","kind":"sale","planned":false,"acquired":false,"shares":2452,"price":95.71,"value":234680.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":923128,"source":{"system":"sec-edgar","filing":"0000907654-26-000096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000090765426000096/form4.xml","form_type":"4"}},{"id":671582,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-09-01T22:35:04.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":1553513,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000907654-26-000087","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000087/form4.xml","form_type":"4"}},{"id":671581,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:35:04.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":4800,"price":92.4357,"value":443691.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.31 to $92.59, inclusive."}],"balance_after":925580,"source":{"system":"sec-edgar","filing":"0000907654-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000087/form4.xml","form_type":"4"}},{"id":671580,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:35:04.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":63596,"price":91.8963,"value":5844237.0948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.28 to $92.27, inclusive."}],"balance_after":930380,"source":{"system":"sec-edgar","filing":"0000907654-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000087/form4.xml","form_type":"4"}},{"id":671579,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:35:04.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":6604,"price":90.7868,"value":599556.0272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.27 to $91.26, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":993976,"source":{"system":"sec-edgar","filing":"0000907654-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000087/form4.xml","form_type":"4"}},{"id":671578,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:35:04.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":75000,"price":7.8,"value":585000.0,"ownership":{"direct":true},"balance_after":1000580,"source":{"system":"sec-edgar","filing":"0000907654-26-000087","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000087/form4.xml","form_type":"4"}},{"id":738558,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:52:55.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":1729,"price":69.69,"value":120494.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":925580,"source":{"system":"sec-edgar","filing":"0000907654-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000062/form4.xml","form_type":"4"}},{"id":741770,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:41:19.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase shares of the Issuer's common stock, which vests in full on the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":34843,"derivative":{"exercise_price":15.22,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":34843},"source":{"system":"sec-edgar","filing":"0001193125-26-267735","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526267735/ownership.xml","form_type":"4"}},{"id":839733,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:10:21.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":1729,"price":41.3,"value":71407.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":927309,"source":{"system":"sec-edgar","filing":"0000907654-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000033/form4.xml","form_type":"4"}},{"id":932711,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-23T22:38:52.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":306700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":306700,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":306700},"source":{"system":"sec-edgar","filing":"0000907654-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000015/form4.xml","form_type":"4"}},{"id":932710,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-23T22:38:52.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":76700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant vests as to 1/16 of the shares on each March 14, June 14, September 14 and December 14 (or if not a trading day, the immediately preceding trading day)."}],"balance_after":929038,"source":{"system":"sec-edgar","filing":"0000907654-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000015/form4.xml","form_type":"4"}},{"id":1162509,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-01T22:10:20.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":23017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer."}],"balance_after":23017,"derivative":{"exercise_price":10.14,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":23017},"source":{"system":"sec-edgar","filing":"0000950170-25-062107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000095017025062107/ownership.xml","form_type":"4"}},{"id":1295911,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-24T21:41:39.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2025."}],"balance_after":230000,"derivative":{"exercise_price":12.5,"expiration_date":"2035-01-21","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001062993-25-001085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000106299325001085/form4.xml","form_type":"4"}},{"id":1861698,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T22:44:16.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":47000,"derivative":{"exercise_price":1.6,"exercise_date":"2024-06-07","expiration_date":"2033-06-07","underlying":"Voting Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001213900-23-047573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000121390023047573/ownership.xml","form_type":"4"}},{"id":2137474,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Stock","published_at":"2022-10-14T00:07:16.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":24500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001213900-22-063947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000121390022063947/ownership.xml","form_type":"4"}},{"id":2179551,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2022-08-18T21:36:02.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full on August 16, 2023, subject to continued service to the Company or any of its subsidiaries."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full on August 16, 2023, subject to continued service to the Company or any of its subsidiaries."}],"balance_after":12500,"derivative":{"underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-046709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122046709/doc4.xml","form_type":"4"}},{"id":2212180,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-06T22:20:16.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":7222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on July 31, 2020, with 100% of the option to vest upon the clearance date of an Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) by the Company with respect to one of its product candidates. On July 5, 2022, in connection with the clearance by the FDA of the Company's IND application for DYNE-251, the Compensation Committee determined that the performance condition had been achieved."}],"balance_after":7222,"derivative":{"exercise_price":5.54,"expiration_date":"2030-07-30","underlying":"Common Stock","underlying_shares":7222},"source":{"system":"sec-edgar","filing":"0001209191-22-041335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000120919122041335/doc4.xml","form_type":"4"}},{"id":2242577,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T20:07:21.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":19596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 3, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":19596,"derivative":{"exercise_price":4.58,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":19596},"source":{"system":"sec-edgar","filing":"0001209191-22-034493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000120919122034493/doc4.xml","form_type":"4"}},{"id":2319667,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-23T22:05:30.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":78045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares subject to the option shall vest on December 7, 2022, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":78045,"derivative":{"exercise_price":3.54,"expiration_date":"2032-03-21","underlying":"Voting Common Stock","underlying_shares":78045},"source":{"system":"sec-edgar","filing":"0001213900-22-014570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1762583/000121390022014570/ownership.xml","form_type":"4"}},{"id":2335506,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T22:03:11.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":9000,"derivative":{"underlying":"Common Shares","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-22-018611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018611/doc4.xml","form_type":"4"}},{"id":2335505,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T22:03:11.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":4584,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 13,750 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 13,750 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."}],"balance_after":4583,"derivative":{"underlying":"Common Shares","underlying_shares":4584},"source":{"system":"sec-edgar","filing":"0001209191-22-018611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018611/doc4.xml","form_type":"4"}},{"id":2335504,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2022-03-14T22:03:11.000Z","date":"2022-03-14","kind":"tax_withholding","acquired":false,"shares":1229,"price":61.08,"value":75067.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":26797,"source":{"system":"sec-edgar","filing":"0001209191-22-018611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018611/doc4.xml","form_type":"4"}},{"id":2335503,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2022-03-14T22:03:11.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":28026,"source":{"system":"sec-edgar","filing":"0001209191-22-018611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018611/doc4.xml","form_type":"4"}},{"id":2335502,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2022-03-14T22:03:11.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":1883,"price":62.56,"value":117800.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":25026,"source":{"system":"sec-edgar","filing":"0001209191-22-018611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018611/doc4.xml","form_type":"4"}},{"id":2335501,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2022-03-14T22:03:11.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":4584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":26909,"source":{"system":"sec-edgar","filing":"0001209191-22-018611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018611/doc4.xml","form_type":"4"}},{"id":2382258,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2022-02-22T22:41:55.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 20,400 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 20,400 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":20400,"derivative":{"underlying":"Common Shares","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0001209191-22-011838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122011838/doc4.xml","form_type":"4"}},{"id":2382257,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-22T22:41:55.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":46200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 18, 2022 with respect to 46,200 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022."}],"balance_after":46200,"derivative":{"exercise_price":58.29,"expiration_date":"2032-02-18","underlying":"Common Shares","underlying_shares":46200},"source":{"system":"sec-edgar","filing":"0001209191-22-011838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122011838/doc4.xml","form_type":"4"}},{"id":2482286,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2021-12-08T01:00:30.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":26667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."}],"balance_after":13333,"derivative":{"underlying":"Common Shares","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0001209191-21-068455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068455/doc4.xml","form_type":"4"}},{"id":2482285,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-12-08T01:00:30.000Z","date":"2021-12-06","kind":"tax_withholding","acquired":false,"shares":11185,"price":69.17,"value":773666.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 3, 2019, the reporting person was granted 40,000 restricted stock units. On December 3, 2021, 26,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":22325,"source":{"system":"sec-edgar","filing":"0001209191-21-068455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068455/doc4.xml","form_type":"4"}},{"id":2482284,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-12-08T01:00:30.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":26667,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":33510,"source":{"system":"sec-edgar","filing":"0001209191-21-068455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068455/doc4.xml","form_type":"4"}},{"id":2540577,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-19T00:00:30.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 15, 2021 with respect to 13,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021."}],"balance_after":13800,"derivative":{"exercise_price":97,"expiration_date":"2031-10-15","underlying":"Common Shares","underlying_shares":13800},"source":{"system":"sec-edgar","filing":"0001209191-21-060776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121060776/doc4.xml","form_type":"4"}},{"id":2570789,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2021-09-15T01:44:27.000Z","date":"2021-09-10","kind":"tax_withholding","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-056092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121056092/doc4.xml","form_type":"4"}},{"id":2570788,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-09-15T01:44:27.000Z","date":"2021-09-13","kind":"tax_withholding","acquired":false,"shares":4207,"price":117.86,"value":495837.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":6843,"source":{"system":"sec-edgar","filing":"0001209191-21-056092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121056092/doc4.xml","form_type":"4"}},{"id":2570787,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-09-15T01:44:27.000Z","date":"2021-09-10","kind":"exercise","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":11050,"source":{"system":"sec-edgar","filing":"0001209191-21-056092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121056092/doc4.xml","form_type":"4"}},{"id":2693687,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T00:38:23.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":19596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 26, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 26, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders"}],"balance_after":19596,"derivative":{"exercise_price":19.56,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":19596},"source":{"system":"sec-edgar","filing":"0000899243-21-020989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000089924321020989/doc4.xml","form_type":"4"}},{"id":2771961,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted on March 10, 2020 with respect to 55,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2020."}],"balance_after":43000,"derivative":{"exercise_price":44.67,"expiration_date":"2030-03-10","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771960,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted on March 5, 2019 with respect to 45,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 5, 2019."}],"balance_after":25000,"derivative":{"exercise_price":40.87,"expiration_date":"2029-03-05","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771959,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the option shall vest on January 2, 2020, and the remaining 75% of the shares shall vest in 36 equal monthly installments on the final day of each month."}],"balance_after":10000,"derivative":{"exercise_price":29.87,"expiration_date":"2029-01-01","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771958,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares shall vest in 48 equal monthly installments on the seventh day of each month, with the first vesting event on April 7, 2018."}],"balance_after":38000,"derivative":{"exercise_price":51.49,"expiration_date":"2028-03-06","underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771957,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the shares shall vest in 48 equal monthly installments on the fifteenth day of each month, with the first vesting event on December 15, 2017."}],"balance_after":3000,"derivative":{"exercise_price":17.66,"expiration_date":"2027-11-14","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771956,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares shall vest in 48 equal monthly installments on the fifteenth day of each month, with the first vesting event on July 15, 2017."}],"balance_after":2666,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-14","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771955,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":12000,"price":126.97,"value":1523640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.80 to $130.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771954,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"sale","acquired":false,"shares":88000,"price":128.2,"value":11281600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.78 to $132.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":13050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771953,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":12000,"price":17.66,"value":211920.0,"ownership":{"direct":true},"balance_after":101050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771952,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":12000,"price":14.43,"value":173160.0,"ownership":{"direct":true},"balance_after":89050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771951,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":20000,"price":40.87,"value":817400.0,"ownership":{"direct":true},"balance_after":77050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771950,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":10000,"price":29.87,"value":298700.0,"ownership":{"direct":true},"balance_after":57050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771949,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":22000,"price":51.49,"value":1132780.0,"ownership":{"direct":true},"balance_after":47050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2771948,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-25T21:39:52.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":12000,"price":44.67,"value":536040.0,"ownership":{"direct":true},"balance_after":25050,"source":{"system":"sec-edgar","filing":"0001209191-21-023069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121023069/doc4.xml","form_type":"4"}},{"id":2792100,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Restricted Stock Units","published_at":"2021-03-12T22:47:58.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":12000,"derivative":{"underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-020257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020257/doc4.xml","form_type":"4"}},{"id":2792099,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T22:47:58.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 11, 2021 with respect to 33,334 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 11, 2021."}],"balance_after":33334,"derivative":{"exercise_price":133.88,"expiration_date":"2031-03-11","underlying":"Common Shares","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001209191-21-020257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020257/doc4.xml","form_type":"4"}},{"id":2792098,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-12T22:47:58.000Z","date":"2021-03-10","kind":"tax_withholding","acquired":false,"shares":2141,"price":124.15,"value":265805.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":13050,"source":{"system":"sec-edgar","filing":"0001209191-21-020257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020257/doc4.xml","form_type":"4"}},{"id":2792097,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-12T22:47:58.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":4583,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 13,750 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":15191,"source":{"system":"sec-edgar","filing":"0001209191-21-020257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020257/doc4.xml","form_type":"4"}},{"id":2792088,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-03-12T22:37:14.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":16334,"price":14.43,"value":235699.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to correct the number of shares acquired on January 15, 2021."}],"balance_after":26942,"source":{"system":"sec-edgar","filing":"0001209191-21-020248","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020248/doc4a.xml","form_type":"4/A","original_submission_date":"2021-01-20"}},{"id":2902414,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":16334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"100% of the shares shall vest in 48 equal monthly installments on the fifteenth day of each month, with the first vesting event on July 15, 2017."}],"balance_after":14666,"derivative":{"exercise_price":14.43,"expiration_date":"2027-06-14","underlying":"Common Shares","underlying_shares":16334},"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902413,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":8666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"100% of the shares shall vest in 48 equal monthly installments on the thirty-first day of each month, with the first vesting event on October 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":12.57,"expiration_date":"2026-07-14","underlying":"Common Shares","underlying_shares":8666},"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902412,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2,"price":219.99,"value":439.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.99 to $219.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902411,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":701,"price":218.54,"value":153196.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.25 to $218.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20002,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902410,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":9997,"price":217.42,"value":2173547.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.22 to $217.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20703,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902409,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1500,"price":216.39,"value":324585.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.00 to $216.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":30700,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902408,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":700,"price":214.6,"value":150220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.60 to $214.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":32200,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902407,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2800,"price":213.64,"value":598192.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.48 to $214.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":32900,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902406,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":634,"price":212.2,"value":134534.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.01 to $212.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":35700,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902405,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":16344,"price":14.43,"value":235843.92,"ownership":{"direct":true},"balance_after":36334,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902404,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":200,"price":217.45,"value":43490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.42 to $217.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902403,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":400,"price":216.24,"value":86496.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.15 to $216.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20200,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902402,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1400,"price":214.46,"value":300244.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.125 to $214.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20600,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902401,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":1200,"price":213.71,"value":256452.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.10 to $214.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902400,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2555,"price":212.54,"value":543039.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.01 to $212.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":23200,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902399,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":2911,"price":211.44,"value":615501.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.01 to $212.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":25755,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2902398,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-20T23:07:27.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":8666,"price":12.57,"value":108931.62,"ownership":{"direct":true},"balance_after":28666,"source":{"system":"sec-edgar","filing":"0001209191-21-004458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004458/doc4.xml","form_type":"4"}},{"id":2925727,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2021-01-04T21:12:35.000Z","date":"2021-01-02","kind":"tax_withholding","acquired":false,"shares":9392,"price":153.11,"value":1438009.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 2, 2019, the reporting person was granted 20,000 restricted stock units. The restricted stock units vested in full on January 2, 2021. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":10608,"source":{"system":"sec-edgar","filing":"0001209191-21-000256","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121000256/doc4.xml","form_type":"4"}},{"id":3011678,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-06T21:38:39.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 05, 2020 with respect to 16,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 05, 2020."}],"balance_after":16666,"derivative":{"exercise_price":86.75,"expiration_date":"2030-10-05","underlying":"Common Shares","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001209191-20-054066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120054066/doc4.xml","form_type":"4"}},{"id":3023934,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-09-23T23:04:47.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":35574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 21, 2020, the Series B Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 21, 2020, the Series B Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 21, 2020, the Series B Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10725},"source":{"system":"sec-edgar","filing":"0000899243-20-026183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000089924320026183/doc4.xml","form_type":"4"}},{"id":3023933,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-09-23T23:04:47.000Z","date":"2020-08-07","kind":"purchase","acquired":true,"shares":35574,"price":2.811,"value":99998.514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B Preferred Stock was convertible into common stock on a 3.3169-for-one basis into the number of shares of common stock shown in Column 7 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B Preferred Stock was convertible into common stock on a 3.3169-for-one basis into the number of shares of common stock shown in Column 7 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series B Preferred Stock was convertible into common stock on a 3.3169-for-one basis into the number of shares of common stock shown in Column 7 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":35574,"derivative":{"underlying":"Common Stock","underlying_shares":10725},"source":{"system":"sec-edgar","filing":"0000899243-20-026183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000089924320026183/doc4.xml","form_type":"4"}},{"id":3023932,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-23T23:04:47.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":14444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on July 31, 2020. The shares underlying the option are scheduled to vest over four years in equal quarterly installments through July 31, 2024."}],"balance_after":14444,"derivative":{"exercise_price":5.54,"expiration_date":"2030-07-30","underlying":"Common Stock","underlying_shares":14444},"source":{"system":"sec-edgar","filing":"0000899243-20-026183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000089924320026183/doc4.xml","form_type":"4"}},{"id":3023931,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-09-23T23:04:47.000Z","date":"2020-07-31","kind":"grant","acquired":true,"shares":11156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on July 31, 2020. The shares underlying the option are scheduled to vest over four years in equal quarterly installments through July 31, 2024."}],"balance_after":11156,"derivative":{"exercise_price":5.54,"expiration_date":"2030-07-30","underlying":"Common Stock","underlying_shares":11156},"source":{"system":"sec-edgar","filing":"0000899243-20-026183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000089924320026183/doc4.xml","form_type":"4"}},{"id":3023930,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T23:04:47.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":10725,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 21, 2020, the Series B Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date."}],"balance_after":10725,"source":{"system":"sec-edgar","filing":"0000899243-20-026183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000089924320026183/doc4.xml","form_type":"4"}},{"id":3098548,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-25","kind":"exercise","acquired":false,"shares":4912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"100% of the shares shall vest in 48 equal monthly installments on the thirty-first day of each month, with the first vesting event on October 31, 2016."}],"balance_after":8666,"derivative":{"exercise_price":12.57,"expiration_date":"2026-07-14","underlying":"Common Shares","underlying_shares":4912},"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098547,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"exercise","acquired":false,"shares":26422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"100% of the shares shall vest in 48 equal monthly installments on the thirty-first day of each month, with the first vesting event on October 31, 2016."}],"balance_after":13578,"derivative":{"exercise_price":12.57,"expiration_date":"2026-07-14","underlying":"Common Shares","underlying_shares":26422},"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098546,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"exercise","acquired":false,"shares":38666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Reporting Person was granted an option to purchase 106,666 shares on March 2, 2016. 43,000 of such options were previously exercised, and the shares underlying those options were sold. 25% of this option became vested and fully exercisable on February 1, 2017, and the remaining 75% of the shares shall vest in 36 equal monthly installments on the first day of each month thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.86,"expiration_date":"2026-03-01","underlying":"Common Shares","underlying_shares":38666},"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098545,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-25","kind":"sale","acquired":false,"shares":4912,"price":75.1776,"value":369272.3712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.6850, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098544,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-25","kind":"exercise","acquired":true,"shares":4912,"price":12.57,"value":61743.84,"ownership":{"direct":true},"balance_after":24912,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098543,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":2913,"price":76.2575,"value":222138.0975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.03 to $76.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098542,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":12175,"price":75.3227,"value":917053.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22913,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098541,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":800,"price":76.5012,"value":61200.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.45 to $76.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":35088,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098540,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":3934,"price":75.937,"value":298736.158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.40 to $76.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":35888,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098539,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":6600,"price":74.8974,"value":494322.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.40 to $75.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":39822,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098538,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"exercise","acquired":true,"shares":26422,"price":12.57,"value":332124.54,"ownership":{"direct":true},"balance_after":46422,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098537,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":22700,"price":76.5011,"value":1736574.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.32 to $76.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098536,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":15966,"price":75.9279,"value":1212264.8514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.32 to $76.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":42700,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3098535,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-06-26T20:33:25.000Z","date":"2020-06-24","kind":"exercise","acquired":true,"shares":38666,"price":5.86,"value":226582.76,"ownership":{"direct":true},"balance_after":58666,"source":{"system":"sec-edgar","filing":"0001209191-20-039086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120039086/doc4.xml","form_type":"4"}},{"id":3150950,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-13T20:38:52.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted an option to purchase 106,666 shares on March 2, 2016. 43,000 of such options were previously exercised, and the shares underlying those options were sold. 25% of this option became vested and fully exercisable on February 1, 2017, and the remaining 75% of the shares shall vest in 36 equal monthly installments on the first day of each month thereafter."}],"balance_after":38666,"derivative":{"exercise_price":5.86,"expiration_date":"2026-03-01","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-028839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120028839/doc4.xml","form_type":"4"}},{"id":3150949,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-05-13T20:38:52.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":682,"price":61.07,"value":41649.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.025 to $61.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-20-028839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120028839/doc4.xml","form_type":"4"}},{"id":3150948,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":18148,"kind":"person","name":"Klein Lawrence Otto","position":1,"cik":"0001762583","reported_name":"Klein Lawrence Otto","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO & COO"}}],"security":"Common Shares","published_at":"2020-05-13T20:38:52.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":24318,"price":60.38,"value":1468320.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20682,"source":{"system":"sec-edgar","filing":"0001209191-20-028839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919120028839/doc4.xml","form_type":"4"}}],"next_cursor":"2020-05-13T20:38:52.000000Z,3150948"}